M. Ouspenskaia

发表

Measurement of residual leukemia during remission in childhood acute lymphoblastic leukemia.

D. Johnston, Z. Estrov, K. McClain, 1997, The New England journal of medicine.

Functional analysis of mutations in TGIF associated with holoprosencephaly.

J. Hahn, D. Wotton, M. Muenke, 2007, Molecular genetics and metabolism.

Reduced NODAL signaling strength via mutation of several pathway members including FOXH1 is linked to human heart defects and holoprosencephaly.

J. Belmont, J. Towbin, M. Muenke, 2008, American journal of human genetics.

The mutational spectrum of holoprosencephaly‐associated changes within the SHH gene in humans predicts loss‐of‐function through either key structural alterations of the ligand or its altered synthesis

S. Bale, A. Paulussen, D. Pineda-Alvarez, 2009, Human mutation.

The full spectrum of holoprosencephaly‐associated mutations within the ZIC2 gene in humans predicts loss‐of‐function as the predominant disease mechanism

S. Bale, A. Paulussen, M. Muenke, 2009, Human mutation.

Truncating loss-of-function mutations of DISP1 contribute to holoprosencephaly-like microform features in humans

P. Beachy, M. Muenke, Yong Ma, 2009, Human Genetics.

Multicolour FISH and quantitative PCR can detect submicroscopic deletions in holoprosencephaly patients with a normal karyotype

I. Gicquel, M. Huizing, L. Pasquier, 2005, Journal of Medical Genetics.

FISH diagnosis of the common 57-kb deletion in CTNS causing cystinosis

W. Gahl, M. Muenke, B. Haddad, 2004, Human Genetics.

Cloning of the chicken α3(IX) collagen chain completes the primary structure of type IX collagen

M. Rest, R. Mayne, R. G. Brewton, 1992 .

Accurate quantitation of residual B-precursor acute lymphoblastic leukemia by limiting dilution and a PCR-based detection system: a description of the method and the principles involved.

D. Johnston, Z. Estrov, Z Estrov, 1995, Leukemia.

Persistence of self-renewing leukemia cell progenitors during remission in children with B-precursor acute lymphoblastic leukemia.

Z. Estrov, D. Harris, D. Pinkel, 1994, Leukemia.

Sumoylation at chromatin governs coordinated repression of a transcriptional program essential for cell growth and proliferation

A. Dejean, M. Benhamed, M. Dasso, 2013, Genome research.

Loss-of-function mutations in growth differentiation factor-1 (GDF1) are associated with congenital heart defects in humans.

A. Schier, J. Belmont, J. Towbin, 2007, American journal of human genetics.

Risk classification at the time of diagnosis differentially affects the level of residual disease in children with B-precursor acute lymphoblastic leukemia after completion of therapy.

D. Johnston, M. Okcu, M. Brandt, 2003, Leukemia research.

Role of granulocyte‐macrophage colony‐stimulating factor in Philadelphia (Ph1)‐positive acute lymphoblastic leukemia: Studies on two newly established Ph1‐positive acute lymphoblastic leukemia cell lines (Z‐119 and Z‐181)

Z. Estrov, R. Kurzrock, H. Kantarjian, 1996, Journal of cellular physiology.

Cumulative ligand activity of NODAL mutations and modifiers are linked to human heart defects and holoprosencephaly.

J. Belmont, J. Towbin, A. Baxevanis, 2009, Molecular genetics and metabolism.

An early requirement for maternal FoxH1 during zebrafish gastrulation.

H. Noushmehr, A. Elkahloun, B. Feldman, 2007, Developmental biology.

Residual leukaemia after bone marrow transplant in children with acute lymphoblastic leukaemia after first haematological relapse or with poor initial presenting features

D. Johnston, N. Bunin, M. Brandt, 2003, British Journal of Haematology.